{"id":69225,"date":"2026-05-13T19:43:08","date_gmt":"2026-05-13T19:43:08","guid":{"rendered":"https:\/\/www.europesays.com\/sk\/69225\/"},"modified":"2026-05-13T19:43:08","modified_gmt":"2026-05-13T19:43:08","slug":"lieky-na-chudnutie-znizuju-riziko-srdcovych-a-cievnych-chorob","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/sk\/69225\/","title":{"rendered":"Lieky na chudnutie zni\u017euj\u00fa riziko srdcov\u00fdch a cievnych chor\u00f4b"},"content":{"rendered":"<p>BRNO &#8211; Nov\u00e9 lieky na chudnutie, takzvan\u00e9 antiobezitik\u00e1, v\u00fdznamne zni\u017euj\u00fa riziko opakovania infarktu, mozgovej m\u0155tvice \u010di \u00famrtia z cievnych pr\u00ed\u010din. Kardiol\u00f3govia preto odpor\u00fa\u010daj\u00fa, aby zdravotn\u00e9 pois\u0165ovne hradili ich pou\u017eitie aj pacientom po z\u00e1va\u017en\u00fdch kardiovaskul\u00e1rnych pr\u00edhod\u00e1ch. O t\u00e9me diskutovali na v\u00fdro\u010dnom zjazde \u010ceskej kardiologickej spolo\u010dnosti v Brne.<\/p>\n<p>\t\t\t\tVe\u013ek\u00e1 \u0161t\u00fadia potvrdila \u00fa\u010dinok<\/p>\n<p>Odpor\u00fa\u010danie kardiol\u00f3gov vych\u00e1dza z medzin\u00e1rodnej \u0161t\u00fadie s \u010deskou \u00fa\u010das\u0165ou, ktor\u00e1 sledovala po\u010das viac ako troch rokov 17.000 pacientov s nadv\u00e1hou alebo obezitou bez diabetu po infarkte, mozgovej pr\u00edhode alebo s ochoren\u00edm perif\u00e9rnych tepien. Uk\u00e1zala, \u017ee lie\u010dba najmodernej\u0161ej gener\u00e1cie liekov na chudnutie zn\u00ed\u017eila v porovnan\u00ed s placebom riziko opakovania z\u00e1va\u017en\u00fdch kardiovaskul\u00e1rnych pr\u00edhod o p\u00e4tinu a \u00famrtnosti o 19 percent.<\/p>\n<p>\t<a href=\"https:\/\/www.topky.sk\/gl\/9570209\/6488143\/Zazrak-modernej-mediciny--Nove-antiobezitika-chrania-srdce-lepsie-nez-doterajsie-liecby--Dalsie-prinosy\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t<img decoding=\"async\" alt=\"Ilustra\u010dn\u00e9 foto\" aria-describedby=\"img-res-6488143\" class=\"\" id=\"6488143\" loading=\"lazy\" onerror=\"imgArticleLoadErr(this)\" src=\"https:\/\/www.europesays.com\/sk\/wp-content\/uploads\/2026\/05\/srdce-kardiolog.jpg\" style=\"aspect-ratio:1.500\" title=\"Ilustra\u010dn\u00e9 foto\"\/>\t\t\t<\/p>\n<p>\n\t\t\t\tZobrazi\u0165 gal\u00e9riu (2)\t\t\t<\/p>\n<p>\t<\/a><\/p>\n<p>Ilustra\u010dn\u00e9 foto\t\u00a0(Zdroj: Getty Images)<\/p>\n<p>&#8222;Uk\u00e1zalo sa, \u017ee lie\u010dba antiobezity vedie k zn\u00ed\u017eeniu z\u00e1palu, k poklesu krvn\u00e9ho tlaku, zlep\u0161eniu lipidov\u00e9ho profilu a \u010fal\u0161\u00edm pozit\u00edvnym metabolick\u00fdm zmen\u00e1m. Vo svetle t\u00fdchto d\u00e1t je potrebn\u00e9 prehodnoti\u0165 pr\u00edstup pois\u0165ovn\u00ed a zv\u00e1\u017ei\u0165 ich finan\u010dn\u00fa podporu u pacientskej popul\u00e1cie bez cukrovky, ktor\u00e1 si v s\u00fa\u010dasnosti lie\u010dbu mus\u00ed hradi\u0165 sama,&#8220;\u00a0uviedol prednosta II. internej kliniky \u2013 kliniky kardiol\u00f3gie a angiol\u00f3gie 1. lek\u00e1rskej fakulty Univerzity Karlovej (1. LF UK) a V\u0161eobecnej fakultnej nemocnice v Prahe (VFN) Ale\u0161 Linhart.<\/p>\n<p>Nov\u00fd poh\u013ead na kardiol\u00f3giu<\/p>\n<p>Nov\u00e9 lieky nielen\u017ee zni\u017euj\u00fa chu\u0165 do jedla a ved\u00fa k v\u00fdraznej redukcii hmotnosti, ale mechanizmus ich \u00fa\u010dinku je ove\u013ea \u0161ir\u0161\u00ed. Pod\u013ea odborn\u00edkov ich tak mo\u017eno vn\u00edma\u0165 nielen ako lieky na cukrovku alebo obezitu, ale aj ako nov\u00fd typ kardiovaskul\u00e1rnej lie\u010dby.<\/p>\n<p>&#8222;Lie\u010dba kardiovaskul\u00e1rnych komplik\u00e1ci\u00ed je mnohon\u00e1sobne n\u00e1kladnej\u0161ia ako samotn\u00e1 farmakoterapia obezity \u010di cukrovky. Aj ke\u010f by tieto lieky pravdepodobne bolo potrebn\u00e9 u\u017e\u00edva\u0165 do\u017eivotne, pr\u00ednos pre pacientov a zdravotn\u00fd syst\u00e9m by mohol by\u0165 z\u00e1sadn\u00fd,&#8220; doplnil prednosta Centra diabetol\u00f3gie IKEM a obezitologickej spolo\u010dnosti \u010ceskej lek\u00e1rskej spolo\u010dnosti Jana Evangelistu Purky\u0148a Martin Haluz\u00edk.<\/p>\n<p>V \u010cesku trpia nadv\u00e1hou alebo obezitou takmer dve tretiny dospelej popul\u00e1cie. Pod\u013ea expertov si pacienti rizik\u00e1 uvedomuj\u00fa a opakovane sa sna\u017eia chudn\u00fa\u0165. &#8222;Doteraj\u0161ie pr\u00edstupy \u2013 najm\u00e4 di\u00e9ty a star\u0161ia farmakologick\u00e1 lie\u010dba \u2013 v\u0161ak \u010dasto zlyh\u00e1vali, \u010di u\u017e pre n\u00edzku dlhodob\u00fa \u00fa\u010dinnos\u0165, alebo pre ne\u017eiaduce \u00fa\u010dinky. V niektor\u00fdch pr\u00edpadoch dokonca zvy\u0161ovali kardiovaskul\u00e1rne riziko, \u010do je presne to, \u010domu sa chceme vyhn\u00fa\u0165,&#8220;\u00a0uviedol Jozef Ko\u0159\u00ednek z II. internej kliniky \u2013 kliniky kardiol\u00f3gie a angiol\u00f3gie 1. LF UK a VFN. Odborn\u00edci sa teraz sna\u017eia zisti\u0165, \u010di by tieto lieky mohli ma\u0165 prevent\u00edvny pr\u00ednos aj u ob\u00e9znych \u013eud\u00ed, ktor\u00ed zatia\u013e \u017eiadnou chorobou srdca netrpeli.<\/p>\n","protected":false},"excerpt":{"rendered":"BRNO &#8211; Nov\u00e9 lieky na chudnutie, takzvan\u00e9 antiobezitik\u00e1, v\u00fdznamne zni\u017euj\u00fa riziko opakovania infarktu, mozgovej m\u0155tvice \u010di \u00famrtia z&hellip;\n","protected":false},"author":2,"featured_media":69226,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[26450,5975,33,43,40,42,36,50,49,48,463],"class_list":{"0":"post-69225","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-svet","8":"tag-kardiologovia","9":"tag-medicina","10":"tag-news","11":"tag-sk","12":"tag-slovak","13":"tag-slovencina","14":"tag-spravy","15":"tag-svet","16":"tag-world","17":"tag-world-news","18":"tag-zdravie"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@sk\/116568981864973663","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/69225","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/comments?post=69225"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/posts\/69225\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media\/69226"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/media?parent=69225"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/categories?post=69225"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/sk\/wp-json\/wp\/v2\/tags?post=69225"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}